1Badr K, Wainwright CL. Inflammation in the cardiovascular system: here, there and everywhere. Curr Opin Pharmacol, 2004, 4:107-109.
2Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, IL-6, and risk of developing type 2 diabetem- ellitus. JAMA Assoc, 2001, 286:327-334.
3Laaksonen DE, Niskanen L, Nyyssonen K, et al.C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia, 2004, 47:1403-1410.
5Dendorfer A, Dominiak P, Schunkert H. ACE inhibitots and angiotensin Ⅱ receptor antagonists. Handb Exp Pharmacol, 2005, 170 : 407-442.
6Irita J, Okura T, Manabe S, et aI. Plasma osteopontin levels are higher in patients with primary aldosteronism than in patients with essential hypertension. Am J Hypertens, 2006, 19(3) :293-299.
9Ding G, Qin Q, He N, et al. Adiponectin and its receptors are expressed in adult ventricular cardiomyo- cytes and upregulated by activation of peroxisome proliferator-activated receptor gamma. J Mol Cell Cardiol, 2007, 43:73-84.
4Scheidegger KJ, Butler S, Witztum JL, et al. Angiotensin Ⅱ modification of low density lipoprotein via a lipoxygenase - dependent pathway.J Biol Chem. 1997,272(34) :21609.
5Touyz RM, Endemann D, He G, et al. Role of AT - Ⅱ receptors in angiotensin Ⅱ stimulated contraction of small mesenteric arteries in young SHR. Hypertens. 1999,33(part Ⅱ ) :366.
6Roman RJ. Altered pressure-natriuresis relationship in young spontaneously hypertensive rats. Hypertension, 1987, 9 (6 Pt 2): Ⅲ130-Ⅲ136.
8Harris RC, McKanna JA, Akai Y, et al. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest, 1994, 94:2504-2510.
9Jensen BL, Kurtz A. Differential regulation of renal cyclooxygenase mRNA by dietary salt intake. Kidney Int, 1997, 52: 1242-1249.
10Yang T, Singh I, Pham H, et al. Regulation of cyclooxygenase expression in the kidney by dietary salt intake. Am J Physiol, 1998, 274(3 Pt 2): F481-F489.
